12:10:48 Europe / Stockholm

Prenumeration

2023-01-09 14:33:00

STENOCARE announced on Monday, January 9th, that products were delivered to its five markets during Q4-22, corresponding to net sales of DKK 2.8m.

Read Analyst Groups comment here


About Analyst Group: One of Sweden's leading equity analysis houses with a focus on small and medium-sized listed companies.
Read more about Analyst Group
 
This is a press release from Analyst Group regarding the publication of comments on STENOCARE. Readers may assume that Analyst Group has received compensation for making the commentary. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.